Biosimilars
-
Alberta government changing drug coverage for 26,000 patients, expects to save up to $380MThe Alberta government is changing its drug coverage for more than 26,000 patients, including those with diabetes, rheumatoid arthritis and Crohn's disease.HealthDec 12, 2019
-
B.C. government becomes first Canadian jurisdiction to shift to cheaper biosimilar drugsThe B.C. government is shifting the type of drugs funded by the provincial health care system.HealthMay 27, 2019
